Stockreport

Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations [Yahoo! Finance]

Tevogen Bio Holdings Inc.  (TVGN) 
PDF immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, nears finalization of agreement with [Read more]